Diabetes
Poster Session 1
Benjamin Pifer, MD (he/him/his)
Yale New Haven Hospital
New Haven, CT, United States
Bertie Geng, MD (she/her/hers)
OBGYN Resident
Yale New Haven Hospital
New Haven, CT, United States
Lisbet S. Lundsberg, MPH, PhD
Associate Research Scientist
Yale
New Haven, CT, United States
Jennifer F. Culhane, MPH, PhD
Associate Research Scientist
Yale University
New Haven, CT, United States
Caitlin Partridge, BA
Senior JDAT Analyst
Yale University
New Haven, CT, United States
Audrey A. Merriam, MD, MS (she/her/hers)
Assistant Professor
Yale University School of Medicine
New Haven, CT, United States
In our analysis of 151 patients, 111 had 3 and 40 had 4 abnormal values. There were no differences in patient characteristics. 84 (55.63%) had a 2-hour GTT or A1c within 1 year of delivery. 63 patients completed either a 2-hour GTT or A1c within 6 weeks postpartum. Of those, 5 (7.94%) met criteria for DM. 46 patients completed either a 2-hour GTT or A1c after 6 weeks postpartum but up to 1 year post-delivery. Of those, 13 (28.26%) met criteria for DM.
Those with 4 abnormal values were more likely to have completed postpartum 2-hour GTT compared to those with 3 abnormal values, p=0.016 (Table). Those who had 4 abnormal values were more likely to be diagnosed with DM postpartum with OR 4.31 (CI 1.49-12.53) compared to those with 3 abnormal values.
Conclusion: Patients with 4 abnormal early 3-hour GTT values were more likely to undergo postpartum DM screening and screen positive for DM compared to those with 3 abnormal values. Many patients with 3 or 4 abnormal values did not complete postpartum DM screening. This work emphasizes the importance of adherence to recommended screening guidelines postpartum and the need for close communication with primary care providers to ensure adequate postpartum DM follow up.